Move with Confidence to Regulatory Submission with CrownBio Non-GLP Toxicology Studies
CrownBio provides Non-GLP Toxicology studies in NHPs and rodent models to provide robust, high quality data, and to allow clients the maximum confidence with regulatory submissions.
Non-GLP Toxicology Studies in NHPs
Using NHP models, CrownBio evaluates agents through a comprehensive assay platform, testing drug physiological and pathological effects. Studies can be rapidly initiated within 2 weeks (dependent on test article availability), with study duration optimized to fit client and project needs.
CrownBio provides healthy NHPs for toxicology studies, as well as our unique collections of spontaneously diabetic, dysmetabolic, and obese NHPs which can provide specific information if a client’s test article(s) is targeted to treat one specific disease.
We offer a range of common agent delivery routes including:
- Intravenous injection or infusion
- Intramuscular injection
- Subcutaneous injection
- Oral routes – via diet or gavage.
As well as having expertise in additional routes such as intraperitoneal injection and intrathecal administration.
Following administration, our comprehensive assessments include tissue and organ collection, as well as a host of assays and parameter collections.
Tissue and Organ Collection |
Assays and Parameter Collection |
---|---|
Blood and other bodily fluid collection |
Clinical observation |
Biopsy of liver, kidney, fat, muscle, skin etc. to fit client needs |
Body weight, food/water consumption |
Gross necropsy (sample number to fit client needs):
|
Blood CBC, PBMC, cell sorting, and chemistry |
Blood pressure, ECG, glucose monitoring (including continuous monitoring) |
|
Hematology and bleeding tests |
|
Bone marrow slides and reading |
|
Urine assay |
|
Histology/IHC |
|
Slide section reading |
Non-GLP Toxicology Studies in Rodent Models
Our toxicology assays can be performed in any commercially available rodent model, or in our proprietary highly translatable models of Type 2 diabetes (MS-NASH (FATZO) mouse, ZDSD rat) or a genetically-relevant model of Polycystic Kidney Disease (pcy mouse) for enhanced studies.
Our main Non-GLP Toxicology capabilities in rodents include:
- Necropsy
- Gross organ weights
- Fixation for histology or rtPCR
- 10% buffered formalin
- OCT cryopreservation
- RNAlater®